FDA-Registered Facility Network
Regenerative Therapies
Simplified Wholesale Access for Clinics
ExaVeyra Sciences partners with FDA-registered 503A and 503B facilities to make wholesale access to cutting-edge regenerative therapies easy and efficient for healthcare clinics across the United States.
Understanding 503A & 503B Facilities
The FDA distinguishes between two types of compounding facilities under the Drug Quality and Security Act (DQSA). ExaVeyra Sciences maintains partnerships with both types to serve diverse clinical needs:
503A Compounding Pharmacies
State-licensed pharmacies preparing patient-specific medications under individual prescriptions. Ideal for personalized treatment protocols and specialty formulations.
503B Outsourcing Facilities
FDA-registered facilities operating under cGMP standards for bulk sterile compounding. Perfect for office-use inventory and high-volume clinical applications.
Quality Assurance: All partner facilities maintain FDA registration, state licensure, and undergo regular inspections to ensure compliance with current Good Manufacturing Practice (cGMP) standards.
Partnership Benefits
FDA-Registered 503A Pharmacies
Access patient-specific compounded medications.
FDA-Registered 503B Facilities
Bulk sterile compounding under cGMP.
Streamlined Wholesale Access
Simplified ordering and dedicated account management.
Regulatory Compliance Support
Full documentation and compliance guidance.
Important Medical & Legal Disclaimer
The information provided on this page is for educational and informational purposes only and is not intended as medical advice. Always seek the advice of your physician or other qualified healthcare provider. Products and therapies mentioned are not intended to diagnose, treat, cure, or prevent any disease. ExaVeyra Sciences provides products exclusively to licensed healthcare professionals.
Ready to Simplify Your Supply Chain?
Join our network of healthcare professionals accessing premium regenerative therapies through FDA-registered facilities.
Regenerative Therapies FAQ
- What is the difference between 503A and 503B compounding facilities?
- 503A pharmacies are state-licensed facilities that compound medications for individual patient prescriptions. 503B outsourcing facilities are FDA-registered and operate under federal cGMP standards, allowing bulk production for office-use inventory. ExaVeyra partners with both types to serve diverse clinical needs.
- How does ExaVeyra Sciences ensure product quality from compounding facilities?
- All ExaVeyra partner facilities maintain FDA registration, state licensure, and undergo regular inspections for cGMP compliance. Every product includes lot tracking and certificates of analysis (COA) available on request. Our founder, an M.Sc. organic chemist, personally verifies product documentation standards.
- What regenerative therapies does ExaVeyra supply through 503A/503B channels?
- ExaVeyra supplies biomolecular signaling vesicles (exosomes) for topical aesthetic use, bioactive peptides, NAD+, glutathione, small molecules, and compounded formulations sourced through FDA-registered 503A and 503B facilities. All products are for licensed healthcare providers only.
- Who can access ExaVeyra's wholesale regenerative therapy supply?
- Wholesale access is available to licensed healthcare providers with a valid NPI number — including physicians, nurse practitioners, physician assistants, and licensed clinics. Applications are reviewed within 1–3 business days.
- Is ExaVeyra Sciences based in Florida?
- Yes. ExaVeyra Sciences is headquartered in Miami, Florida. We serve licensed clinics and practitioners across Florida, the Southeast, and nationwide with cold-chain fulfillment and dedicated account management.